Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica de La Rioja (58)

2024

  1. Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain

    AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314

  2. Gut microbiota produces biofilm-associated amyloids with potential for neurodegeneration

    Nature Communications, Vol. 15, Núm. 1

  3. High-Performance Liquid Chromatography–Fluorescence Detection Method for Ochratoxin A Quantification in Small Mice Sample Volumes: Versatile Application across Diverse Matrices Relevant for Neurodegeneration Research

    Toxins, Vol. 16, Núm. 5

  4. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

  5. Polyphenols and metabolism: from present knowledge to future challenges

    Journal of Physiology and Biochemistry, Vol. 80, Núm. 3, pp. 603-625

  6. Status of head and neck brachytherapy in Spain in 2022

    Clinical and Translational Oncology, Vol. 26, Núm. 2, pp. 456-460

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Plasma fractalkine contributes to systemic myeloid diversity and PD-L1/PD-1 blockade in lung cancer

    EMBO Reports, Vol. 24, Núm. 8

  3. The Regulators of Peroxisomal Acyl-Carnitine Shuttle CROT and CRAT Promote Metastasis in Melanoma

    Journal of Investigative Dermatology, Vol. 143, Núm. 2, pp. 305-316.e5

  4. Transcriptomic Analysis Reveals JAK2/MPL-Independent Effects of Calreticulin Mutations in a C. elegans Model

    Cells, Vol. 12, Núm. 1

2022

  1. Analysis of the albumin-bilirubin score as an indicator of improved liver function among hepatitis C virus patients with sustained viral response after direct-acting antiviral therapy

    JGH Open, Vol. 6, Núm. 7, pp. 496-502

  2. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  3. The role of PSMA radioligands in the diagnosis and treatment of prostate carcinoma

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 41, Núm. 2, pp. 126-135

2021

  1. Biomonitoring of mycotoxins in plasma of patients with alzheimer’s and parkinson’s disease

    Toxins, Vol. 13, Núm. 7

  2. Crmp2 as a candidate target to interfere with lung cancer cell migration

    Biomolecules, Vol. 11, Núm. 10

  3. Oral Sub-chronic Ochratoxin A Exposure Induces Gut Microbiota Alterations in Mice

    Toxins, Vol. 13, Núm. 2

  4. Oral subchronic exposure to the mycotoxin ochratoxin A induces key pathological features of Parkinson's disease in mice six months after the end of the treatment

    Food and Chemical Toxicology, Vol. 152

  5. The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant

    Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414

2020

  1. FDG PET/CT in colorectal cancer

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 39, Núm. 1, pp. 57-66

2019

  1. 18F-FDG PET/CT in locally advanced cervical cancer: A review

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 38, Núm. 1, pp. 59-68